Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir
Sign Up to like & getrecommendations! Published in 2024 at "Toxicological Sciences"
DOI: 10.1093/toxsci/kfae112
Abstract: Abstract Molnupiravir is registered or authorized in several countries as a 5-d oral coronavirus disease 2019 treatment for adults. Molnupiravir is a prodrug of the antiviral ribonucleoside β-D-N4-hydroxycytidine (NHC) that distributes into cells, where it… read more here.
Keywords: genotoxicity carcinogenicity; carcinogenicity study; molnupiravir; comprehensive genotoxicity ... See more keywords